Adjuvant
Showing 9976 - 10000 of >10,000
Breast Cancer Trial (adjuvant therapy, conventional surgery, hypofractionated radiation therapy)
Completed
- Breast Cancer
- adjuvant therapy
- +3 more
- (no location specified)
Aug 9, 2011
Breast Cancer Trial in Worldwide (exemestane, tamoxifen citrate)
Completed
- Breast Cancer
- exemestane
- tamoxifen citrate
-
Liverpool, New South Wales, Australia
- +47 more
Jun 29, 2012
Coagulation Trial in Ottawa (Vitamin K1 (Phytonadione), Placebo)
Completed
- Coagulation
- Vitamin K1 (Phytonadione)
- Placebo
-
Ottawa, Ontario, CanadaOttawa Hospital Thrombosis Clinic
Jul 26, 2011
Malignant Mesothelioma Trial in Zurich (cisplatin, gemcitabine HCl, conventional surgery)
Completed
- Malignant Mesothelioma
- cisplatin
- +2 more
-
Zurich, SwitzerlandUniversitaetsSpital
May 14, 2012
Anemia, Breast Tumors, Hemoglobins Trial (epoetin alfa)
Terminated
- Anemia
- +4 more
- epoetin alfa
- (no location specified)
May 17, 2011
Quantifying Micro RNA Levels of Colon
Unknown status
- Colorectal Carcinoma (CRC) Patients
-
Kfar-Saba, IsraelMeir Medical Center
Oct 23, 2012
Colorectal Cancer Trial in Switzerland (capecitabine and oxaliplatin + cetuximab, capecitabine and oxaliplatin)
Completed
- Colorectal Cancer
- capecitabine and oxaliplatin + cetuximab
- capecitabine and oxaliplatin
-
Aarau, Switzerland
- +17 more
Jun 4, 2012
Melanoma Trial run by the NCI (Glycoprotein 100 (GP100): 209-217 (210M), Interleukin-2 (IL-2), Montanide ISA 51)
Completed
- Melanoma
- Glycoprotein 100 (GP100): 209-217 (210M)
- +5 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Oct 17, 2012
Breast Cancer Trial in United States (drug, genetic, other)
Terminated
- Breast Cancer
- erlotinib hydrochloride
- +4 more
-
Macon, Georgia
- +8 more
Aug 3, 2012
Schizophrenia Trial in Belmont, Boston (Sarcosine)
Completed
- Schizophrenia
- Sarcosine
-
Belmont, Massachusetts
- +1 more
Sep 17, 2012
Breast Cancer, Arthralgia Trial in Buffalo (Exercising block)
Completed
- Breast Cancer
- Arthralgia
- Exercising block
-
Buffalo, New YorkRoswell Park Cancer Institute
Apr 12, 2012
Melanoma Trial in New York (GM-CSF DNA, NSC 683472 gp100: 209-217(210M), NSC 699048 Tyrosinase: 368-376(370D))
Completed
- Melanoma
- GM-CSF DNA, NSC 683472 gp100: 209-217(210M), NSC 699048 Tyrosinase: 368-376(370D)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 9, 2011
Non-metastatic Prostate Cancer Trial in Canada, United States (Bicalutamide, Placebo)
Completed
- Non-metastatic Prostate Cancer
- Bicalutamide
- Placebo
-
Birmingham, Alabama
- +84 more
Jun 5, 2012
Prostate Cancer Trial in Nashville (Docetaxel, Estramustine)
Completed
- Prostate Cancer
-
Nashville, TennesseeTennessee Oncology, PLLC
May 2, 2011
Relapsed Breast Cancer, Tumors, Breast Trial in United States (Lapatinib, Capecitabine, Docetaxel)
Terminated
- Relapsed Breast Cancer
- Neoplasms, Breast
- Lapatinib
- +3 more
-
Hot Springs, Arkansas
- +27 more
May 31, 2012
Brain Tumors Trial in Amsterdam (Neurofeedback, Placebo feedback)
Unknown status
- Brain Tumors
- Neurofeedback
- Placebo feedback
-
Amsterdam, Noord Holland, NetherlandsAcademic Medical Centre - UvA
Oct 3, 2012
HIV Trial in France (adjuvanted A(H1N1)v influenza vaccine, non-adjuvanted A(H1N1)v influenza vaccine)
Completed
- HIV Infections
- adjuvanted A(H1N1)v influenza vaccine
- non-adjuvanted A(H1N1)v influenza vaccine
-
Créteil, France
- +5 more
Dec 21, 2011
Lung Cancer Trial in Worldwide (BCG vaccine, mAb BEC2)
Completed
- Lung Cancer
- BCG vaccine
- monoclonal antibody BEC2
-
Birmingham, Alabama
- +76 more
Mar 5, 2012
Use of ROTEM for Multi-level Spine Surgery
Completed
- Coagulation
-
New York, New YorkWeill Cornell Medical College
Mar 2, 2012